Koss-Olinger Consulting’s HCA Healthcare HCA Stock Holding History

Koss-Olinger Consulting’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-527	Closed	-$249K	–	209
2026 Q1	$249K	Sell	527 -1	-0.2%	-$503	0.02%	237
2025 Q4	$247K	Sell	528 -377	-42%	-$175K	0.02%	252
2025 Q3	$347K	Hold	905	–	–	0.03%	248
2025 Q2	$347K	Sell	905 -38	-4%	-$13.7K	0.03%	249
2025 Q1	$326K	Buy	+943	New	+$303K	0.03%	251
2024 Q4	–	Sell	-942	Closed	-$383K	–	228
2024 Q3	$383K	Hold	942	–	–	0.03%	195
2024 Q2	$303K	Buy	+942	New	+$306K	0.03%	211
2024 Q1	–	Sell	-955	Closed	-$258K	–	147
2023 Q4	$258K	Hold	955	–	–	0.03%	257
2023 Q3	$235K	Hold	955	–	–	0.03%	235
2023 Q2	$290K	Hold	955	–	–	0.03%	188
2023 Q1	$252K	Sell	955 -29	-3%	-$7.37K	0.03%	200
2022 Q4	$236K	Buy	+984	New	+$220K	0.03%	187
2022 Q2	–	Sell	-894	Closed	-$224K	–	197
2022 Q1	$224K	Sell	894 -326	-27%	-$81.9K	0.04%	171
2021 Q4	$313K	Buy	+1,220	New	+$299K	0.05%	150

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Koss-Olinger Consulting's HCA Position: Q2 2026 in Review

Koss-Olinger Consulting sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 527 shares — an estimated $249K sold.

Koss-Olinger Consulting first reported a position in HCA in Q4 2021 and held it in 14 quarters. The position peaked at $383K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Koss-Olinger Consulting reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Koss-Olinger Consulting sold 527 HCA Healthcare shares in Q2 2026, an estimated $249K.
Koss-Olinger Consulting first reported a position in HCA Healthcare in Q4 2021 and held it in 14 quarters.
Koss-Olinger Consulting's HCA Healthcare position peaked at $383K in Q3 2024.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Koss-Olinger Consulting's 13F filing for Q2 2026, filed 10 Aug 2026.